Viewing Study NCT06786234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2026-02-20 @ 10:34 PM
Study NCT ID: NCT06786234
Status: RECRUITING
Last Update Posted: 2025-07-09
First Post: 2025-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essential Thrombocythaemia
Sponsor: Step Pharma, SAS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Essential Thrombocythaemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Essential Thrombocythemia View
None High risk View
None Resistant to or Intolerant of Hydroxycarbamide Therapy View
None Resistant to or Intolerant of Hydroxyurea Therapy View
None Oral therapy View